142 related articles for article (PubMed ID: 32880626)
1. Outcomes of a Telephone-Based Questionnaire for Follow-up of Patients Who Have Completed Curative-Intent Treatment for Oral Cancers.
Malik A; Nair S; Sonawane K; Lamba K; Ghosh-Laskar S; Prabhash K; Pai P; Chaukar D; Nair D; Chaturvedi P
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1102-1108. PubMed ID: 32880626
[TBL] [Abstract][Full Text] [Related]
2. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense?
de Visscher AV; Manni JJ
Arch Otolaryngol Head Neck Surg; 1994 Sep; 120(9):934-9. PubMed ID: 8074820
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Symptom-based remote assessment in post-treatment head and neck cancer surveillance: A prospective national study.
Zhang H; Hardman JC; Tikka T; Nankivell P; Mehanna H; Paleri V;
Clin Otolaryngol; 2022 Sep; 47(5):561-567. PubMed ID: 35634790
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.
Merkx MA; van Gulick JJ; Marres HA; Kaanders JH; Bruaset I; Verbeek A; de Wilde PC
Head Neck; 2006 Jan; 28(1):1-7. PubMed ID: 16155911
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U
Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
9. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients.
Kothari P; Trinidade A; Hewitt RJD; Singh A; O'Flynn P
Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1191-1200. PubMed ID: 21193920
[TBL] [Abstract][Full Text] [Related]
10. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.
Patil V; Noronha V; Dhumal SB; Joshi A; Menon N; Bhattacharjee A; Kulkarni S; Ankathi SK; Mahajan A; Sable N; Nawale K; Bhelekar A; Mukadam S; Chandrasekharan A; Das S; Vallathol D; D'Souza H; Kumar A; Agrawal A; Khaddar S; Rathnasamy N; Shenoy R; Kashyap L; Rai RK; Abraham G; Saha S; Majumdar S; Karuvandan N; Simha V; Babu V; Elamarthi P; Rajpurohit A; Kumar KAP; Srikanth A; Ravind R; Banavali S; Prabhash K
Lancet Glob Health; 2020 Sep; 8(9):e1213-e1222. PubMed ID: 32827483
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of follow-up activities after curative treatment for head and neck cancer.
Pagh A; Grau C; Overgaard J
Acta Oncol; 2015 May; 54(5):813-9. PubMed ID: 25907822
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node biopsy in lieu of neck dissection for staging oral cancer.
Rigual N; Loree T; Frustino J; Jayaprakash V; Cohan D; Sullivan M; Kuriakose MA
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):779-82. PubMed ID: 23868306
[TBL] [Abstract][Full Text] [Related]
14. Assessment of tissue autofluorescence and reflectance for oral cavity cancer screening.
Sweeny L; Dean NR; Magnuson JS; Carroll WR; Clemons L; Rosenthal EL
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):956-60. PubMed ID: 21804026
[TBL] [Abstract][Full Text] [Related]
15. Three-year follow-up of sentinel node-negative patients with early oral cavity squamous cell carcinoma.
Sebbesen L; Bilde A; Therkildsen M; Mortensen J; Specht L; von Buchwald C
Head Neck; 2014 Aug; 36(8):1109-12. PubMed ID: 23804530
[TBL] [Abstract][Full Text] [Related]
16. Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.
Lim WY; Morton RL; Turner RM; Jenkins MC; Guitera P; Irwig L; Webster AC; Dieng M; Saw RPM; Low D; Low C; Bell KJL
JAMA Dermatol; 2018 Apr; 154(4):420-427. PubMed ID: 29490373
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.
Albaba H; Barnes TA; Veitch Z; Brown MC; Shakik S; Su S; Naik H; Wang T; Liang M; Perez-Cosio A; Eng L; Mittmann N; Xu W; Howell D; Liu G
Oncologist; 2019 Nov; 24(11):e1219-e1227. PubMed ID: 31409744
[TBL] [Abstract][Full Text] [Related]
18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure.
Peethambaram P; Weiss M; Loprinzi CL; Novotny P; O'Fallon JR; Erlichman C; O'Connell MJ; Laurie JA
Oncology; 1997; 54(4):287-92. PubMed ID: 9216852
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a truncated surveillance schedule for patients following curative intent treatment for carcinoma of the oral cavity.
Manikantan K; Jain PV; Sharan R; Arun P
Int J Oral Maxillofac Surg; 2022 Aug; 51(8):987-991. PubMed ID: 34772601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
